CClinicalTrials.gg
CompletedNCT03265600MINDFUL-PC-2Updated Nov 25, 2020Results posted

Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)

An interventional study of Mindfulness Training for Primary Care and 60-minute Introduction to Mindfulness in Depression, Anxiety and Stress Related Disorder, sponsored by Cambridge Health Alliance. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-25.

Sponsored by Cambridge Health Alliance · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Among primary care patients, compare the effectiveness of an 8-week mindfulness-based intervention (Mindfulness Training for Primary Care[MTPC]) vs. a low-dose mindfulness introduction comparator on self-management of chronic illness and illness-related health behavior action plan initiation, as well as on measures related to anxiety, depression, and stress.

Read the detailed description

This study builds on a pilot study that investigated the impact of Mindfulness Training for Primary Care on anxiety, depression, stress, and chronic illness self-management in primary care patients receiving care in an urban, community, multi-cultural safety net healthcare system. The current comparative effectiveness randomized controlled trial takes place in a larger sample, and investigates the impact of a refined MTPC curriculum on specific aspects of self-regulation such as action plan initiation, while examining potential mechanisms of change, including self-efficacy, perceived control, mindfulness, self-compassion, emotion regulation, and body awareness. Participants randomized to MTPC are compared with participants who are randomized to a low-dose comparator condition and receive a 1-hour introduction to mindfulness with a referral to community mindfulness resources. Outcome assessments are conducted at baseline and study weeks 8-10.

02

Conditions studied

  • Depression
  • Anxiety
  • Stress Related Disorder
  • Adjustment Disorders

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current CHA patient with an enrolled CHA primary care doctor.
  • CHA patients 18 years of age and older.
  • Able to tolerate and participate in interviews and engage in all procedures.
  • Able to give written consent in English OR willing and able to provide consent and complete assessments through a professional language translator when necessary.
  • Diagnosis eligible to be covered by insurance for group visits (e.g., anxiety disorder, depression, or adjustment disorder related to chronic illness, pain, etc.).

Exclusion criteria

Exclusion Criteria:

  • Any cognitive impairment that precludes informed consent.
  • Patients who, in the opinion of the Principal Investigator, pose an imminent risk of suicide or danger to self or others.
  • Likelihood of potential incarceration such as a conviction or pending charges that may potentially result in imprisonment.
  • Previous enrollment or randomization of treatment in the present study within the 12 months.
  • Behaviors that may cause disruption to a mindfulness group.
  • Patients with symptoms of psychosis, thought disorder, and/or severe mental illness, including schizophrenia, schizoaffective, bipolar disorder, or a current severe episode of major depressive disorder.
  • Lack of insurance coverage for group psychotherapy may preclude participation in groups.
  • Patients in their third trimester of pregnancy who foresee conflicts that preclude their commitment to completing all activities.
  • Patients with highly unstable medical problems that put them at a high risk of hospitalization.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
136 participants (actual)

Study arms

  • Active comparator
    Mindfulness Training for Primary Care

    Mindfulness Training for Primary Care (MTPC) is a primary care adaptation that includes core common Mindfulness-Based Intervention (MBI) elements integrated with novel mindfulness-oriented behavior change elements into a format that is adaptable to delivery in primary care health centers.

    Behavioral: Mindfulness Training for Primary Care

  • Other
    Low-dose Comparator

    Comparator arm: Participants receive a 60-minute introduction to mindfulness group plus referral to a list of community mindfulness resources such as private-pay community mindfulness classes, mobile mindfulness applications, books, and online recordings. These participants are added to a 6-month wait-list for a Cambridge Health Alliance mindfulness-based intervention group and allowed to receive behavioral and medical referrals and treatment as usual. All participants complete an action planning protocol during Week 7.

    Behavioral: 60-minute Introduction to Mindfulness

Interventions

  • BehavioralMindfulness Training for Primary Care

    MTPC is a referral-based, insurance-reimbursable 8-week program that can be delivered as group psychotherapy by Patient-Centered Medical Home-integrated behavioral clinicians or as an 8-week primary care group visit delivered by a primary care provider. MTPC groups are 2 hours long for 8 weeks with a 7-hour weekend day of silent practice. MTPC emphasizes mindfulness-oriented skills for self-regulation, self-management of chronic illness, and health behavior change. All participants complete an action planning protocol during Week 7.

  • Behavioral60-minute Introduction to Mindfulness

    Participants in the low-dose comparator arm receive a 60-minute introduction to mindfulness. Participants are introduced to the definition(s) of mindfulness, brief mindfulness practices, discussion, and an orientation to an 8-week mindfulness group. They are also given a list of leading community, online, print, and smartphone mindfulness resources.

05

What researchers measure

Primary outcomes

  1. Action Plan Initiation Survey (APIS-5)

    The Action Plan Initiation Survey (APIS-5) is a 5-item self-report questionnaire adapted from a measure used by Guck et al. Participants are asked to indicate how successful they were in meeting a previously set Action Plan by using a 7-point Likert scale from 1 (Not met at all) to 7 (Totally met), with a score of 5 or above indicating successful initiation of the goal. For each unmet goal, patients are asked to further rate the cause of not meeting the goal by using a 7-point Likert rating scale from 1 (Extremely controllable) to 7 (Not at all controllable). For this outcome we reported the number of participants in each arm who successfully initiated an Action Plan, as indicated by a score of 5 or above in reporting whether they were able to meet their action plan goal.

    Time frame: Weeks 8-10

  2. Perceived Stress Scale

    The Perceived Stress Scale (PSS) (10 items) measures the degree to which situations in life are stressful. Items are designed to evaluate how overloaded, unpredictable, and uncontrollable one finds one's life. Each item is scored on a 5 point Likert scale from 0 (Never) to 4 (Very often). Scores range from 0-40 with higher scores reflecting worse results (more stress).

    Time frame: Baseline and week 8 (pre to post Intervention)

  3. Patient Reported Outcomes Measurement Information System - Anxiety Short Form (PROMIS-ASF)

    The Patient Reported Outcomes Measurement Information System - Anxiety Short Form 8a (PROMIS-ASF) is an 8-item scale used to assess patient-reported health status for anxiety. PROMIS instruments are funded by the National Institutes of Health (NIH) and used to reliably and validly measure patient-reported outcomes for clinical research and practice. Participants are asked to rate their experience of the item in the past seven days on a 5-point Likert scale from 1 (Never) to 5 (Always). The values of the response to each question are summed into a raw score ranging from 8-40. The raw score is then rescaled with use of the PROMIS Assessment Center Scoring Service into a T score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher T-Score reflects worse results (greater symptom severity).

    Time frame: Baseline and week 8 (pre to post Intervention)

  4. Patient Reported Outcomes Measurement Information System - Depression Short Form (PROMIS-DSF)

    The Patient Reported Outcomes Measurement Information System - Depression Short Form 8a (PROMIS-DSF) is an 8-item scale used to assess patient-reported health status for depression. PROMIS instruments are funded by the National Institutes of Health (NIH) and used to reliably and validly measure patient-reported outcomes for clinical research and practice. Participants are asked to rate their experience of the item in the past seven days on a 5-point Likert scale from 1 (Never) to 5 (Always). The values of the response to each question are summed into a raw score ranging from 8-40. The raw score is then rescaled with use of the PROMIS Assessment Center Scoring Service into a T score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher T-Score reflects reflect worse results (greater symptom severity).

    Time frame: Baseline and week 8 (pre to post Intervention)

Secondary outcomes

  1. Five Facet Mindfulness Questionnaire (FFMQ)

    The Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item scale that examines five factors that represent aspects of the current empirical conception of mindfulness. These five facets include: "observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience." Participants rate their degree of agreement with each of the items on a Likert-type scale ranging from 1 (Never or very rarely true) to 5 (Very often or always true). Facet scores range from 8-40, with the exception of the nonreactivity facet, which ranges from 7-35. Total scores range from 39-195, with higher scores reflecting higher levels of mindfulness (a better outcome).

    Time frame: Baseline and week 8 (pre to post Intervention)

  2. Self-Compassion Scale-Short Form (SCS-SF)

    The short-form Self-Compassion Scale (SCS-SF) is an abbreviated 12-item form of the original 26-item Self-Compassion Scale. The scale is scored on a 5 point Likert scale (1 = Almost never; 5 = Almost always), and negative subscale items are reverse scored, with higher scores indicating greater levels of self-compassion.

    Time frame: Baseline and week 8 (pre to post Intervention)

  3. Change in Self-Efficacy for Managing Chronic Disease (SECD-6)

    The Self-Efficacy for Managing Chronic Disease Scale (SECD-6) is a 6-item scale that is used to evaluate a participant's ability to self-manage care for a chronic disease. SECD-6 asks participants to rate their confidence in their own ability to do certain activities, on a scale from 1 (not at all confident) to 10 (totally confident). Higher scores indicate better results (higher levels of self-efficacy).

    Time frame: Baseline and week 8 (pre to post Intervention)

  4. Perceived Control Questionnaire (PCQ)

    The Perceived Control Questionnaire (PCQ) is adapted from a 5-item perceived control measure from Jerant et al. and a previously validated survey from Armitage et al. This 5-item scale asks participants to rate their sense of control over chronic illness self-management on a 7-point scale from 1 (None) to 7 (Total). Scores range from 5-35, with higher scores indicating better results (greater sense of control).

    Time frame: Baseline and week 8 (pre to post Intervention)

  5. Difficulty in Emotion Regulation Scale (DERS)

    The Difficulties in Emotion Regulation (DERS) Scale is a 36-item self-report scale designed to assess emotional dysregulation. Participants are asked to rate how often they have emotional dysregulation on a 5-point Likert scale from 1 (almost never \[0-10%\]) to 5 (almost always \[91-100%\]). The scale assess 6 aspects of emotional dysregulation: non-acceptance of emotional responses, difficulties engaging in goal directed behavior, impulse control difficulties, lack of emotional awareness (reverse-scored), limited access to emotion regulation strategies, and lack of emotional clarity. Total scores range from 5-180, with higher scores indicating worse results (more difficulty in emotional regulation).

    Time frame: Baseline and week 8 (pre to post Intervention)

  6. Multidimensional Assessment of Interoceptive Awareness (MAIA)

    The Multidimensional Assessment of Interoceptive Awareness (MAIA) is a 32-item self-report scale designed to assess 8 aspects of interoceptive awareness : noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trusting. Participants are asked to rate their awareness of interoceptive experiences on a 6-point Likert scale from 0 (Never) to 5 (Always). Each subscale has 3-7 items, and scores are obtained by reverse coding items 5, 6, 7, 8, 9, and then taking the average of items in each scale. Scores range from 0-5, with higher scores indicating better results (greater interoception).

    Time frame: Baseline and week 8 (pre to post Intervention)

06

Results

Posted Dec 3, 2019

Participant flow

Participants were recruited from 11 metro-north Boston primary care Patient Centered Medical Homes via print and digital flyers, as well as referrals from primary and mental health care settings confirmed by a primary care provider. 465 participants were recruited.

Participant flow — Overall Study
MilestoneMindfulness Training for Primary CareLow-dose Comparator
Started9244
Completed6832
Not completed2412
Withdrew: Lost to follow-up175
Withdrew: Withdrawal by subject42
Withdrew: Partially completed 8 wk or 24 wk survey35

Outcome measures

PrimaryAction Plan Initiation Survey (APIS-5)

The Action Plan Initiation Survey (APIS-5) is a 5-item self-report questionnaire adapted from a measure used by Guck et al. Participants are asked to indicate how successful they were in meeting a previously set Action Plan by using a 7-point Likert scale from 1 (Not met at all) to 7 (Totally met), with a score of 5 or above indicating successful initiation of the goal. For each unmet goal, patients are asked to further rate the cause of not meeting the goal by using a 7-point Likert rating scale from 1 (Extremely controllable) to 7 (Not at all controllable). For this outcome we reported the number of participants in each arm who successfully initiated an Action Plan, as indicated by a score of 5 or above in reporting whether they were able to meet their action plan goal.

Time frame:
Weeks 8-10
Reported as:
Count of participants · Participants
Action Plan Initiation Survey (APIS-5)
ParticipantsMindfulness Training for Primary CareLow-dose Comparator
Action Plan Initiation Survey (APIS-5)5314
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Unadjusted bivariate logistic regression · p = 0.006 · Odds ratio (or): 2.91
PrimaryPerceived Stress Scale

The Perceived Stress Scale (PSS) (10 items) measures the degree to which situations in life are stressful. Items are designed to evaluate how overloaded, unpredictable, and uncontrollable one finds one's life. Each item is scored on a 5 point Likert scale from 0 (Never) to 4 (Very often). Scores range from 0-40 with higher scores reflecting worse results (more stress).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Perceived Stress Scale
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline25.0 ± 6.724.3 ± 6.6
8 Weeks19.9 ± 6.320.9 ± 6.3
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.19Cohen's d: -0.25
PrimaryPatient Reported Outcomes Measurement Information System - Anxiety Short Form (PROMIS-ASF)

The Patient Reported Outcomes Measurement Information System - Anxiety Short Form 8a (PROMIS-ASF) is an 8-item scale used to assess patient-reported health status for anxiety. PROMIS instruments are funded by the National Institutes of Health (NIH) and used to reliably and validly measure patient-reported outcomes for clinical research and practice. Participants are asked to rate their experience of the item in the past seven days on a 5-point Likert scale from 1 (Never) to 5 (Always). The values of the response to each question are summed into a raw score ranging from 8-40. The raw score is then rescaled with use of the PROMIS Assessment Center Scoring Service into a T score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher T-Score reflects worse results (greater symptom severity).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Patient Reported Outcomes Measurement Information System - Anxiety Short Form (PROMIS-ASF)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline63.9 ± 6.961.9 ± 6.6
8 Weeks58.5 ± 6.658.9 ± 6.9
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.12Cohen's d: -0.36
PrimaryPatient Reported Outcomes Measurement Information System - Depression Short Form (PROMIS-DSF)

The Patient Reported Outcomes Measurement Information System - Depression Short Form 8a (PROMIS-DSF) is an 8-item scale used to assess patient-reported health status for depression. PROMIS instruments are funded by the National Institutes of Health (NIH) and used to reliably and validly measure patient-reported outcomes for clinical research and practice. Participants are asked to rate their experience of the item in the past seven days on a 5-point Likert scale from 1 (Never) to 5 (Always). The values of the response to each question are summed into a raw score ranging from 8-40. The raw score is then rescaled with use of the PROMIS Assessment Center Scoring Service into a T score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher T-Score reflects reflect worse results (greater symptom severity).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Patient Reported Outcomes Measurement Information System - Depression Short Form (PROMIS-DSF)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline59.2 ± 8.658.0 ± 8.6
8 Weeks53.9 ± 7.955.6 ± 8.0
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.08Cohen's d: -0.34
SecondaryFive Facet Mindfulness Questionnaire (FFMQ)

The Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item scale that examines five factors that represent aspects of the current empirical conception of mindfulness. These five facets include: "observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience." Participants rate their degree of agreement with each of the items on a Likert-type scale ranging from 1 (Never or very rarely true) to 5 (Very often or always true). Facet scores range from 8-40, with the exception of the nonreactivity facet, which ranges from 7-35. Total scores range from 39-195, with higher scores reflecting higher levels of mindfulness (a better outcome).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Five Facet Mindfulness Questionnaire (FFMQ)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline115.8 ± 18.2115.6 ± 24.5
8 Weeks132.0 ± 16.9119.4 ± 26.4
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = <0.001Cohen's d: 0.57
SecondarySelf-Compassion Scale-Short Form (SCS-SF)

The short-form Self-Compassion Scale (SCS-SF) is an abbreviated 12-item form of the original 26-item Self-Compassion Scale. The scale is scored on a 5 point Likert scale (1 = Almost never; 5 = Almost always), and negative subscale items are reverse scored, with higher scores indicating greater levels of self-compassion.

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Self-Compassion Scale-Short Form (SCS-SF)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline2.6 ± 0.672.6 ± 0.73
8 Weeks3.1 ± 0.652.8 ± 0.69
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.03Cohen's d: 0.41
SecondaryChange in Self-Efficacy for Managing Chronic Disease (SECD-6)

The Self-Efficacy for Managing Chronic Disease Scale (SECD-6) is a 6-item scale that is used to evaluate a participant's ability to self-manage care for a chronic disease. SECD-6 asks participants to rate their confidence in their own ability to do certain activities, on a scale from 1 (not at all confident) to 10 (totally confident). Higher scores indicate better results (higher levels of self-efficacy).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Change in Self-Efficacy for Managing Chronic Disease (SECD-6)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline6.1 ± 1.96.2 ± 2.0
8 Weeks6.7 ± 1.66.5 ± 1.7
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.31Cohen's d: 0.15
SecondaryPerceived Control Questionnaire (PCQ)

The Perceived Control Questionnaire (PCQ) is adapted from a 5-item perceived control measure from Jerant et al. and a previously validated survey from Armitage et al. This 5-item scale asks participants to rate their sense of control over chronic illness self-management on a 7-point scale from 1 (None) to 7 (Total). Scores range from 5-35, with higher scores indicating better results (greater sense of control).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Perceived Control Questionnaire (PCQ)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline23.5 ± 4.423.0 ± 4.4
8 Weeks25.3 ± 4.223.8 ± 4.3
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = 0.26Cohen's d: 0.22
SecondaryDifficulty in Emotion Regulation Scale (DERS)

The Difficulties in Emotion Regulation (DERS) Scale is a 36-item self-report scale designed to assess emotional dysregulation. Participants are asked to rate how often they have emotional dysregulation on a 5-point Likert scale from 1 (almost never \[0-10%\]) to 5 (almost always \[91-100%\]). The scale assess 6 aspects of emotional dysregulation: non-acceptance of emotional responses, difficulties engaging in goal directed behavior, impulse control difficulties, lack of emotional awareness (reverse-scored), limited access to emotion regulation strategies, and lack of emotional clarity. Total scores range from 5-180, with higher scores indicating worse results (more difficulty in emotional regulation).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Difficulty in Emotion Regulation Scale (DERS)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline76.1 ± 23.072.2 ± 23.2
8 Weeks60.2 ± 21.868.8 ± 21.8
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = <0.001Cohen's d: -0.58
SecondaryMultidimensional Assessment of Interoceptive Awareness (MAIA)

The Multidimensional Assessment of Interoceptive Awareness (MAIA) is a 32-item self-report scale designed to assess 8 aspects of interoceptive awareness : noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trusting. Participants are asked to rate their awareness of interoceptive experiences on a 6-point Likert scale from 0 (Never) to 5 (Always). Each subscale has 3-7 items, and scores are obtained by reverse coding items 5, 6, 7, 8, 9, and then taking the average of items in each scale. Scores range from 0-5, with higher scores indicating better results (greater interoception).

Time frame:
Baseline and week 8 (pre to post Intervention)
Reported as:
Mean · score on a scale
Multidimensional Assessment of Interoceptive Awareness (MAIA)
score on a scaleMindfulness Training for Primary CareLow-dose Comparator
Baseline2.4 ± 0.732.5 ± 0.73
8 Weeks3.1 ± 0.642.6 ± 0.69
Statistical analysis
  • Mindfulness Training for Primary Care vs Low-dose Comparator · Mixed Models Analysis · p = <0.001Cohen's d: 0.75

Adverse events

Collected over Participants completed a self-reported adverse events form during weeks 8 and 24. Adverse events were further collected during engagement phone calls during weeks 2, 4 6, and 8 using a combination of checklist and open-ended questions.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mindfulness Training for Primary Care0/92 (0%)4/92 (4.3%)8/92 (8.7%)
Low-dose Comparator0/44 (0%)0/44 (0%)4/44 (9.1%)
Most frequent serious events
Most frequent serious events
EventMindfulness Training for Primary CareLow-dose Comparator
Diagnosed with colon cancerGastrointestinal disorders1/92—
Psychiatric hospitalization, hypomanic episodePsychiatric disorders1/92—
Psychiatric hospitalization, increased PTSD symptomsPsychiatric disorders1/92—
Psychiatric hospitalization, suicidal ideationPsychiatric disorders1/92—
Most frequent other events
Showing 10 of 11
Most frequent other events
EventMindfulness Training for Primary CareLow-dose Comparator
Back injuryInjury, poisoning and procedural complications2/921/44
Binge drinkingPsychiatric disorders0/921/44
ED visit due to hearing loss, ear pain, tinnitusEar and labyrinth disorders0/921/44
Admission for flu and UTIRenal and urinary disorders0/921/44
ED visit for alcohol abusePsychiatric disorders1/920/44
Motor vehicle accidentInjury, poisoning and procedural complications1/920/44
Motor vehicle accidentInjury, poisoning and procedural complications1/920/44
ED visit after alleged sexual assaultSocial circumstances1/920/44
Flashback during MTPC All-Day SessionPsychiatric disorders1/920/44
Increased Anxiety during Open Awareness PracticePsychiatric disorders1/920/44

Baseline characteristics

Age, Continuous
Age, Continuous(years)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Mean40.6 ± 12.740.3 ± 12.240.5 ± 12.5
Sex: Female, Male
Sex: Female, Male(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Female632689
Male291847
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Ethnicity — Hispanic17421
Ethnicity — Non-Hispanic7540115
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Race — White7332105
Race — Black347
Race — Other16824
English as second language
English as second language(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Count of participants19524
Annual Income <$20,000
Annual Income <$20,000(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Count of participants31940
Marital Status
Marital Status(Participants)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Single442367
Married/cohabitating321749
Divorced13215
Widowed112
Other213
Education
Education(years)Mindfulness Training for Primary CareLow-dose ComparatorTotal
Mean16.6 ± 3.115.5 ± 4.116.2 ± 3.4

7 further baseline measures are reported on the registry.

07

Study locations

1 site
  • Cambridge Health Alliance
    Somerville, Massachusetts 02143, United States
08

References and documents

Publications

  • Demarzo MM, Montero-Marin J, Cuijpers P, Zabaleta-del-Olmo E, Mahtani KR, Vellinga A, Vicens C, Lopez-del-Hoyo Y, Garcia-Campayo J. The Efficacy of Mindfulness-Based Interventions in Primary Care: A Meta-Analytic Review. Ann Fam Med. 2015 Nov;13(6):573-82. doi: 10.1370/afm.1863. PubMed 26553897 ↗
  • Mccubbin T, Dimidjian S, Kempe K, Glassey MS, Ross C, Beck A. Mindfulness-based stress reduction in an integrated care delivery system: one-year impacts on patient-centered outcomes and health care utilization. Perm J. 2014 Fall;18(4):4-9. doi: 10.7812/TPP/14-014. PubMed 25662520 ↗
  • Sundquist J, Lilja A, Palmer K, Memon AA, Wang X, Johansson LM, Sundquist K. Mindfulness group therapy in primary care patients with depression, anxiety and stress and adjustment disorders: randomised controlled trial. Br J Psychiatry. 2015 Feb;206(2):128-35. doi: 10.1192/bjp.bp.114.150243. Epub 2014 Nov 27. PubMed 25431430 ↗
  • Merkes M. Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health. 2010;16(3):200-10. doi: 10.1071/PY09063. PubMed 20815988 ↗
  • Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM, Ranasinghe PD, Linn S, Saha S, Bass EB, Haythornthwaite JA. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014 Mar;174(3):357-68. doi: 10.1001/jamainternmed.2013.13018. PubMed 24395196 ↗
  • Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010 Apr;78(2):169-83. doi: 10.1037/a0018555. PubMed 20350028 ↗
  • Holzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective. Perspect Psychol Sci. 2011 Nov;6(6):537-59. doi: 10.1177/1745691611419671. PubMed 26168376 ↗
  • Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62. PubMed 11769298 ↗
  • Schuman-Olivier Z, Hoeppner BB, Evins AE, Brewer JA. Finding the right match: mindfulness training may potentiate the therapeutic effect of nonjudgment of inner experience on smoking cessation. Subst Use Misuse. 2014 Apr;49(5):586-94. doi: 10.3109/10826084.2014.850254. PubMed 24611853 ↗
  • Alegria M, Sribney W, Perez D, Laderman M, Keefe K. The role of patient activation on patient-provider communication and quality of care for US and foreign born Latino patients. J Gen Intern Med. 2009 Nov;24 Suppl 3(Suppl 3):534-41. doi: 10.1007/s11606-009-1074-x. PubMed 19842003 ↗
  • Neff KD, Germer CK. A pilot study and randomized controlled trial of the mindful self-compassion program. J Clin Psychol. 2013 Jan;69(1):28-44. doi: 10.1002/jclp.21923. Epub 2012 Oct 15. PubMed 23070875 ↗
  • Wiegner L, Hange D, Bjorkelund C, Ahlborg G Jr. Prevalence of perceived stress and associations to symptoms of exhaustion, depression and anxiety in a working age population seeking primary care--an observational study. BMC Fam Pract. 2015 Mar 19;16:38. doi: 10.1186/s12875-015-0252-7. PubMed 25880219 ↗
  • Benzo RP. Mindfulness and motivational interviewing: two candidate methods for promoting self-management. Chron Respir Dis. 2013 Aug;10(3):175-82. doi: 10.1177/1479972313497372. PubMed 23897933 ↗
  • Gawande R, To MN, Pine E, Griswold T, Creedon TB, Brunel A, Lozada A, Loucks EB, Schuman-Olivier Z. Mindfulness Training Enhances Self-Regulation and Facilitates Health Behavior Change for Primary Care Patients: a Randomized Controlled Trial. J Gen Intern Med. 2019 Feb;34(2):293-302. doi: 10.1007/s11606-018-4739-5. Epub 2018 Dec 3. PubMed 30511291 ↗

Study documents

  • Protocol and statistical analysis plan · Jun 27, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03265600
Lead sponsor
Cambridge Health Alliance
Collaborators
The Arthur Vining Davis Foundations, The Arnold P. Gold Foundation, National Institutes of Health (NIH), Brown University, National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Sponsor
First posted
Aug 29, 2017
Start date
Feb 1, 2017
Primary completion
Sep 15, 2018
Completion
Aug 1, 2020
Results posted
Dec 3, 2019
Last update
Nov 25, 2020

Study contacts

Zev D Schuman-Olivier, MD
principal investigator · Cambridge Health Alliance

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion